SYNSENSO officially kicked-off!
On October 14, 2022, the SYNSENSO consortium got together for a half-day virtual kick-off meeting, setting the tone for the upcoming years of joint research and collaboration.
Last week, over 20 members of the SYNSENSO consortium gathered to officially kick-off the new Horizon Europe MSCA-DN SYNSENSO. After an introductory session hosted by project coordinator Prof. Dr. Heinz Koeppl (TUDa), the floor was offered to the SYNSENSO Associated partners at Imperial College London, BRAIN Biotech, LenioBio, University of Naples Federico II, Abvance Biotech, BioMérieux, Nuclera and accelopment Schweiz to introduce themselves to the consortium, and give insights into their companies and the planned participation in SYNSENSO – including the numerous industry secondments offered to the SYNSENSO DCs. Besides, the consortium used the time to go over the planned network-wide training events that are awaiting the DCs later on in the project.
The first SYNSENSO Doctoral Candidates are almost ready to start and begin their research under SYNSENSO. (All DCs and their supervisors will be introduced here shortly.) To stay up to date with the project and our DCs, follow SYNSENSO on our social media channels below.
Follow SYNSENSO on Twitter and LinkedIn: